Viracta Therapeutics (VIRX) Q4 2022 Earnings

13MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.47
-0.4
-0.34
-0.27

Details

Expected EPS
-0.38
Actual EPS
-0.27
Surprise EPS
0.11
Surprise Percent
+28.95%

Description

Viracta Therapeutics (VIRX) has reported earnings of -0.27 per share for Q4 2022.

0 Comments

Share your thoughts